BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29718744)

  • 21. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment.
    Düzovali O
    Med Pediatr Oncol; 1999 Feb; 32(2):154-5. PubMed ID: 9950209
    [No Abstract]   [Full Text] [Related]  

  • 22. Unique MRI findings as an early predictor of osteonecrosis in pediatric acute lymphoblastic leukemia.
    Sansgiri RK; Neel MD; Soto-Fourier M; Kaste SC
    AJR Am J Roentgenol; 2012 May; 198(5):W432-9. PubMed ID: 22528924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
    Badhiwala JH; Nayiager T; Athale UH
    Pediatr Blood Cancer; 2015 Oct; 62(10):1851-4. PubMed ID: 25931304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [MRI follow-up study of aseptic osteonecrosis (AON) in children treated with chemotherapy for malignant diseases].
    Scherer A; Engelbrecht V; Krauth KA; Bernbeck B; Reinwand U; Willers R; Göbel U; Mödder U
    Klin Padiatr; 2001; 213(2):56-62. PubMed ID: 11305193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
    Kawedia JD; Kaste SC; Pei D; Panetta JC; Cai X; Cheng C; Neale G; Howard SC; Evans WE; Pui CH; Relling MV
    Blood; 2011 Feb; 117(8):2340-7; quiz 2556. PubMed ID: 21148812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia.
    Mogensen SS; Schmiegelow K; Grell K; Albertsen BK; Wehner PS; Kampmann P; Frandsen TL
    Haematologica; 2017 May; 102(5):e175-e178. PubMed ID: 28209659
    [No Abstract]   [Full Text] [Related]  

  • 27. Lower-limb MRI in the staging and re-staging of osteonecrosis in paediatric patients affected by acute lymphoblastic leukaemia after therapy.
    Ippolito D; Masetto A; Franzesi CT; Bonaffini PA; Sala A; Biondi A; Sironi S
    Skeletal Radiol; 2016 Apr; 45(4):495-503. PubMed ID: 26782927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Whole-body MR imaging in children with suspected osteonecrosis after intensive chemotherapy: preliminary results].
    Beer M; Stenzel M; Girschick H; Schlegel PG; Darge K
    Rofo; 2008 Mar; 180(3):238-45. PubMed ID: 18278731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 2, clinical and imaging patterns.
    Karimova EJ; Rai SN; Ingle D; Ralph AC; Deng X; Neel MD; Howard SC; Pui CH; Kaste SC
    AJR Am J Roentgenol; 2006 Feb; 186(2):477-82. PubMed ID: 16423956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteonecrosis in Children and Adolescents With Acute Lymphoblastic Leukemia: Early Diagnosis and New Treatment Strategies.
    Biddeci G; Bosco G; Varotto E; Corradin M; Geranio G; Tridello G; Pillon M; Carraro E; Garetto G; Assadi R; Gigante C; Putti MC
    Anticancer Res; 2019 Mar; 39(3):1259-1266. PubMed ID: 30842156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships among severity of osteonecrosis, pain, range of motion, and functional mobility in children, adolescents, and young adults with acute lymphoblastic leukemia.
    Marchese VG; Connolly BH; Able C; Booten AR; Bowen P; Porter BM; Rai SN; Hancock ML; Pui CH; Howard S; Neel MD; Kaste SC
    Phys Ther; 2008 Mar; 88(3):341-50. PubMed ID: 18202079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On a case of multifocal osteonecrosis in a patient suffering from acute lymphoblastic leukemia.
    Solarino G; Scialpi L; Bruno M; De Cillis B
    Chir Organi Mov; 2008 Sep; 92(2):119-22. PubMed ID: 18473129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
    Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
    Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow magnetic resonance studies in childhood leukemia. Evaluation of osteonecrosis.
    Pieters R; van Brenk AI; Veerman AJ; van Amerongen AH; van Zanten TE; Golding RP
    Cancer; 1987 Dec; 60(12):2994-3000. PubMed ID: 3479230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia.
    Inaba H; Cao X; Chang JY; Karol SE; Panetta JC; Ness KK; Cheng C; Pui CH; Relling MV; Kaste SC
    Br J Haematol; 2020 May; 189(4):e177-e181. PubMed ID: 32207157
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone marrow changes on MRI in children with acute lymphoblastic leukaemia 5 years after treatment.
    Ojala AE; Pääkkö E; Lanning FP; Harila-Saari AH; Lanning BM
    Clin Radiol; 1998 Feb; 53(2):131-6. PubMed ID: 9502090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aseptic osteonecrosis in children with acute lymphoblastic leukemia.
    Körholz D; Bruder M; Engelbrecht V; Rüther W; Göbel U
    Pediatr Hematol Oncol; 1998; 15(4):307-15. PubMed ID: 9658431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.
    Finch ER; Janke LJ; Smith CA; Karol SE; Pei D; Cheng C; Kaste SC; Inaba H; Pui CH; Wolf J; Relling MV
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27669. PubMed ID: 30758124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteonecrosis in children with acute lymphoblastic leukemia: a 10-year study from northern Greece.
    Tragiannidis A; Athanassiadou F; Papageorgiou T; Petsatodis G; Sidi V; Koliouskas D
    Pediatr Blood Cancer; 2007 Oct; 49(5):764. PubMed ID: 17216599
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia.
    Janke LJ; Van Driest SL; Portera MV; Atreya RV; Denny JC; Pei D; Cheng C; Kaste SC; Inaba H; Jeha S; Pui CH; Relling MV; Karol SE
    Blood; 2019 Sep; 134(12):983-986. PubMed ID: 31409674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.